Rhythm Pharmaceuticals buy Citigroup Inc.
Start price
17.03.26
/
50%
€77.50
Target price
17.03.27
€113.94
Performance (%)
28.39%
Price
08:32
?
Summary
This prediction is currently active. The prediction currently has a performance of 28.39%. This prediction currently runs until 17.03.27. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Rhythm Pharmaceuticals | -2.970% | -2.970% |
| iShares Core DAX® | -1.059% | 5.007% |
| iShares Nasdaq 100 | -2.387% | 0.864% |
| iShares Nikkei 225® | -4.361% | 1.211% |
| iShares S&P 500 | -1.778% | 1.391% |
Comments by Citigroup_Inc_ for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals (RYTM) had its price target lowered by Citigroup Inc. from $136.00 to $131.00. They now have a "buy" rating on the stock.
Ratings data for RYTM provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€96.00
05.08.26
05.08.26
€123.95
05.08.27
05.08.27
3.65%
08:32
08:32
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€93.00
27.11.25
27.11.25
€117.12
27.11.26
27.11.26
6.99%
08:32
08:32